azides has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, S; Kamei, J; Miyata, S | 1 |
| Appel, NM; Hokari, M; Holman, GD; Koehler-Stec, EM; Maher, F; Oki, J; Simpson, IA; Smith, QR; Vannucci, SJ | 1 |
2 other study(ies) available for azides and Alloxan Diabetes
| Article | Year |
|---|---|
Involvement of diazepam-insensitive benzodiazepine receptors in the suppression of DOI-induced head-twitch responses in diabetic mice.
Topics: Amphetamines; Animals; Azides; Behavior, Animal; Benzodiazepines; Bicuculline; Diabetes Mellitus, Experimental; Diazepam; Flumazenil; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Male; Mice; Mice, Inbred ICR; Receptors, GABA-A; Serotonin Receptor Agonists | 2006 |
Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.
Topics: Affinity Labels; Animals; Azides; Blood-Brain Barrier; Diabetes Mellitus, Experimental; Disaccharides; Glucose; Glucose Transporter Type 1; Glycosides; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Monosaccharide Transport Proteins; Photochemistry; Propylamines; Rats; Rats, Sprague-Dawley; Tritium | 1999 |